Randomized phase II trial (RENO): Efficacy results of oral vinorelbine or etoposide combined with cisplatin in chemo-radiotherapy treatment of locally advanced NSCLC (LA-NSCLC)-SLCG 10/02.

被引：2
|
作者：
Provencio, Mariano
de las Penas, Ramon
Insa, Amelia
Martinez-Banaclocha, Natividad
Fabregat, Raquel Marse
Sanchis, Pilar Mut
Moran, Teresa
Sala, Angeles
Massuti, Bartomeu
Ortega, Ana Laura
Jurado, Jose Miguel
Gomez-Codina, Jose
Diz, Pilar
Artal-Cortes, Angel
Calderon, Vanesa Gutierrez
Vazquez, Maria Francisca
Vinolas, Nuria
Quintana, Miguel Angel Munoz
Garcia-Gomez, Ramon
Isla, Dolores
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.8538
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8538
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Safety and Efficacy Trial of Cisplatin (P) and Vinorelbine (V) Followed by Gefitinib (G) and Concurrent Thoracic Radiotherapy (TRT) for Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) JCOG0402
    Ohe, Yuichiro
    Ishikura, Satoshi
    Yokoyama, Akira
    Atagi, Shinji
    Shibata, Taro
    Tamura, Tomohide
    Saijo, Nagahiro
    Fukuoka, Masahiro
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S401 - S402
  • [22] Oral vinorelbine versus etoposide with cisplatin and chemo-radiation as treatment in patients with stage III non-small cell lung cancer: A randomized phase II (RENO study)
    Isla, Dolores
    De Las Penas, Ramon
    Insa, Amelia
    Marse, Raquel
    Martinez-Banaclocha, Natividad
    Mut, Pilar
    Moran, Teresa
    Angeles Sala, Maria
    Massuti, Bartomeu
    Laura Ortega, Ana
    Miguel Jurado, Jose
    Gomez-Codina, Jose
    Diz, Pilar
    Artal, Angel
    Gutierrez, Vanesa
    Francisca Vazquez, Maria
    Vinolas, Nuria
    Maestu, Inmaculada
    Camps, Carlos
    Alvarez, Rosa
    de Mon Soto, Melchor Alvarez
    Ponce, Santiago
    Provencio, Mariano
    LUNG CANCER, 2019, 135 : 161 - 168
  • [23] CONCOMITANT RADIOTHERAPY (RT) WITH A FRACTIONATED DOSE OF ORAL VINORELBINE(NVBO) AND CISPLATIN (CDDP) AFTER INDUCTION CHEMOTHERAPY (CT) IN LOCALLY ADVANCED NON SMALL CELL LUNG CANCER(LA NSCLC). FIRST RESULTS OF A PHASE II STUDY
    Zalcman, G.
    Riviere, A.
    Gervais, R.
    Lerouge, D.
    Dansin, E.
    Dujon, C.
    Chouaid, C.
    Precheur-Agulhon, B.
    Biville-Hedouin, F.
    Lartigau, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 95 - 95
  • [24] A randomised, controlled, multicenter phase II trial of camrelizumab combined with albumin-bound paclitaxel and cisplatin as neoadjuvant treatment in locally advanced NSCLC
    Lei, J.
    Yan, X.
    Zhao, J.
    Tian, F.
    Lu, Q.
    Jiang, T.
    ANNALS OF ONCOLOGY, 2020, 31 : S1441 - S1442
  • [25] Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer - Final results of an international phase II trial
    Krzakowski, Maciej
    Provencio, Mariano
    Utracka-Hutka, Beata
    Villa, Eugenio
    Codes, Manuel
    Kuten, Abraham.
    Henke, Michael
    Lopez, Massimo
    Bell, David
    Biti, Giampaolo
    Merimsky, Ofer
    Beorchia, Aulo
    Riggi, Marcello
    Caux, Noel-Raphael
    Pouget, Jean-Christophe
    Dubray, Bernard
    David, Philippe
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (09) : 994 - 1002
  • [26] Safety and efficacy trial of cisplatin (P) with vinorelbine (V) followed by gefitinib (G) and concurrent thoracic radiotherapy (TRT) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC): Japan Clinical Oncology Group (JCOG) 0402
    Ohe, Y.
    Nishiwaki, Y.
    Yokoyama, A.
    Kawahara, M.
    Takeda, K.
    Shibata, T.
    Tamura, T.
    Saijo, N.
    Fukuoka, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [27] Efficacy evaluation of concurrent nivolumab addition to a first-line, concurrent chemo-radiotherapy regimen in unresectable locally advanced NSCLC: Results from the European Thoracic Oncology Platform (ETOP 6-14) NICOLAS phase II trial
    Peters, S.
    Felip, E.
    Dafni, U.
    Tufman, A.
    Guckenberger, M.
    Irigoyen, A.
    Nadal, E.
    Becker, A.
    Vees, H.
    Pless, M.
    Martinez-Marti, A.
    Lambrecht, M.
    Andratschke, N.
    Tsourti, Z.
    Piguet, A-C.
    Roschitzki-Voser, H.
    Rabaglio-Poretti, M.
    Stahel, R. A.
    Vansteenkiste, J. F.
    De Ruysscher, D.
    ANNALS OF ONCOLOGY, 2019, 30 : 591 - 591
  • [28] An Open Label, Multicenter Clinical Study of Cetuximab Combined with Concurrent Chemo-radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: Preliminary Results of a Phase II Trial
    Yu, J.
    Wang, J. H.
    Sun, X. D.
    Wang, L. H.
    Zhu, G. Y.
    Feng, P. B.
    Ye, M.
    Lu, Y.
    Zhu, S. C.
    Liao, Z. X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S309 - S309
  • [29] Randomized Phase II Trial of Metformin in Combination with Chemoradiotherapy (CRT) in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC); the OCOG-ALMERA trial (NCT02115464)
    Tsakiridis, T.
    Pond, G.
    Wright, J.
    Ellis, P.
    Abdulkarim, B. S.
    Ahmed, N.
    Robinson, A. G.
    Valdes, M.
    Okawara, G.
    Swaminath, A.
    Wierzbicki, M.
    Levine, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S104 - S104
  • [30] ORAL VINORELBINE (NVBO) plus CISPLATIN (CDDP) AS CHEMORADIOTHERAPY (CT-RT) TREATMENT (TRT) AFTER INDUCTION IN LOCALLY ADVANCED NON SMALL CELL LUNG CANCER (NSCLC): RESULTS OF A PHASE II STUDY
    Lerouge, D.
    Zalcman, G.
    Riviere, A.
    Dansin, E.
    Gervais, R.
    Dujon, C.
    Chouaid, C.
    Lavole, A.
    Precheur-Agulhon, B.
    Biville-Hedouin, F.
    Lartigau, E.
    ANNALS OF ONCOLOGY, 2010, 21 : 135 - 135
12345